The two-year competitive ban imposed on UT track star Justin Gatlin by the International Association of Athletics Federations has been lifted.
At its recent quarterly meeting in Paris, the IAAF Council reduced the two-year penalty to the one year he already has served. The ban resulted from a positive test for amphetamine use at the USA Track & Field Junior National Championships in the summer of 2001. The amphetamine, however, was contained within a prescription medication Gatlin had taken for years to treat Attention Deficit Disorder.
To prove that the substance is not performance-enhancing, Gatlin ran last year at UT without medication and won the NCAA indoor 60- and 200-meter titles, then took the 100 and 200 sprints at the NCAA outdoors.
The ban did not affect Gatlin's collegiate career; only IAAF-sanctioned competitions such as the recent 2002 USA national championships.